BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kutlu R, Karatoprak S. Radioembolization for Hepatocellular Carcinoma in Downstaging and Bridging for Liver Transplantation. J Gastrointest Cancer 2020;51:1157-64. [PMID: 32880041 DOI: 10.1007/s12029-020-00492-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhu Y, Xu J, Hu W, Wang F, Zhou Y, Gong W, Xu W. Inhibiting USP8 overcomes hepatocellular carcinoma resistance via suppressing receptor tyrosine kinases. Aging (Albany NY) 2021;13:14999-5012. [PMID: 34081623 DOI: 10.18632/aging.203061] [Reference Citation Analysis]
2 Ekmekcioglu O, Tabakci ON, Bozdag Kaplan N, Hasanefendioglu Bayrak A, Battal M. Factors affecting the response to treatment and survival in hepatocellular carcinoma patients treated with transarterial radioembolisation: a single-centre experience. Eur J Gastroenterol Hepatol 2021;33:926-31. [PMID: 33731592 DOI: 10.1097/MEG.0000000000002117] [Reference Citation Analysis]
3 Hassan SA, Ali AAH, Sohn D, Flögel U, Jänicke RU, Korf HW, von Gall C. Does timing matter in radiotherapy of hepatocellular carcinoma? An experimental study in mice. Cancer Med 2021;10:7712-25. [PMID: 34545699 DOI: 10.1002/cam4.4277] [Reference Citation Analysis]